Story
Dermapharm Reports 2.9% Revenue Growth in First Half, Reaffirms 2026 Guidance

Dermapharm Holding SE announced preliminary first-half 2026 revenue of €591 million, a 2.9% increase from the prior-year period, driven by growth in its core branded pharmaceuticals business. The German drugmaker reaffirmed its full-year financial guidance, signaling confidence in its performance for the remainder of the year.
First-Half Financials
According to the company's preliminary report, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the six-month period reached €163.20 million. Total EBITDA was reported at €184.50 million.
Key performance indicators for the first half of 2026 include:
- Revenue: €591 million
- Adjusted EBITDA: €163.20 million
- Adjusted EBITDA Margin: 31.20%
Segment Performance Breakdown
AdThe primary growth driver was the Branded Pharmaceuticals segment, which benefited from both organic expansion and the initial contributions from the acquisitions of Mucos Group and F. Trenka. This performance offset weaker results in other divisions.
Conversely, the Other Healthcare Products segment experienced a moderate revenue decline, which Dermapharm attributed to weaker consumer purchasing power. The company noted that earnings in this division were supported by favorable exchange rates and lower material costs. The Parallel Imports segment saw an expected drop in revenue following a strategic portfolio realignment, though its profitability improved due to a focus on higher-margin products.
Full-Year Outlook Confirmed
Dermapharm maintained its full-year 2026 forecast, projecting revenue between €1,182 million and €1,218 million. The company's outlook for adjusted EBITDA also remains unchanged, targeted in a range of €331 million to €341 million. Management stated that it anticipates positive trends across all segments in the second half of 2026.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.